Pharmaceutical Technology

MAY 25, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. Side effects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.

Side effects 52

Side effects Medicine Recruitment Doctors 52

World of DTC Marketing

JULY 17, 2022

Novo Nordisk more than doubled its sales targets for obesity drugs to $3.7bn by 2025. It has to persuade patients to sign up for some heinous side effects. When patients stop taking Wegovy, their appetite returns within weeks, and they pack on weight. Its share price has risen 26 percent in the past year.

Side effects 209

Side effects Doctors Insurance Prescription 209

European Pharmaceutical Review

NOVEMBER 2, 2023

This evidence included comparisons of the products on an analytical level using chemical and biological tests and assays that confirmed similarity in the structural and functional features of Wezlana and Stelara, as well as comparative human pharmacokinetic data, clinical immunogenicity data and other clinical safety and effectiveness data.

Food and Drug Administration 98

Food and Drug Administration FDA Side effects Safety 98

Pharma Marketing Network

NOVEMBER 15, 2024

Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influencers and Patient Stories 5 Analyze and Optimize Regularly 1. Are you trying to engage healthcare professionals (HCPs), patients, or caregivers?

Media 52

Media Pharma Marketing Medical 52

European Pharmaceutical Review

OCTOBER 17, 2024

Additionally, EURneffy could alleviate the risk of accidental needle-related side effects (such as injection into the blood vessel and hand) 3 and it has the attributes of being smaller in size, has better temperature sensitivity, and is less complex to use compared to needle-based injectors. Motohiro E, Kento T, Kyohei T , et al.

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

pharmaphorum

AUGUST 19, 2022

Grünenthal has moved its painkiller resiniferatoxin into phase 3 trials in patients with osteoarthritis, hoping to find an option that sidesteps the side effects and addictive potential of opioid drugs. If all goes well, the aim is to bring resiniferatoxin to market in 2025.

Side effects 52

Side effects Recruitment Patients Safety 52

European Pharmaceutical Review

SEPTEMBER 5, 2024

Cancer-associated fibroblasts, and their effects of the immune activity in the tumour, are considered one of the main reasons why around four out of five patients do not benefit from immunotherapies such as checkpoint inhibitors. For the 28 patients who received only pembrolizumab, the OS was 58 percent.

Medicine 59

Medicine Side effects Marketing Patients 59